- The hemp-CBD industry is estimated to reach $22 billion by 2020
- While still focusing on providing financial information and services, ChineseInvestors.com also aims to be a recognizable leader in the hemp-based CBD oil industry
- The company is considering a Nasdaq IPO for subsidiary CBD Biotech Co. Ltd. by late FY2019 or the following year
ChineseInvestors.com Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and Canada, is looking to gain momentum in its hemp-based CBD product and service division through a variety of avenues.
Aside from retail, online and direct sales of hemp-based products, the company has also historically offered customers a wide variety of products and services, including real-time market commentary, as well as analysis and education-related services in Chinese language character sets.
ChineseInvestors.com has cultivated a highly diversified revenue stream and has made inroads into the growing cannabis and CBD oil industry in several ways. The company developed a Chinese language application for the cannabis industry, and, in 2016, it launched a new website which could distribute industrial hemp-based CBD products.
ChineseInvestors.com aims to be a recognizable leader in the hemp-based CBD oil industry. In China, hemp-based CBD is legal as an additive to cosmetics, and this allows for a potential market of nearly two billion people desirous of quality CBD-infused products. As a standalone market distinct from cannabis itself, the hemp-CBD market is estimated to reach $22 billion by 2022, according to a study by the Brightfield Group (http://cnw.fm/HB2w9). As more of mainland China’s population sees the benefits of CBD oil products, the blossoming industry is poised for strong growth in that region.
Another aspect of ChineseInvestors.com’s growth strategy can be seen in the company’s acquisition of foreign enterprise CBD Biotech Co. Ltd. Referring to its pursuit of a national securities exchange listing for CBD Biotech, ChineseInvestors.com CEO and founder Warren Wang said in a news release (http://cnw.fm/oe8yN), “This is a part of a series of actions we have put into place to execute…our strategic plan to spin-out CBD Biotech.”
Wang continued, stating his belief that “listing on a national exchange speaks to the quality of CBD Biotech, will provide us with market visibility and access to capital, and further support our growth strategy.” He mentioned that the company hopes for a Nasdaq IPO of CBD Biotech late in FY2019 or early the following year (http://cnw.fm/9UvLO).
For more information, visit the company’s website at www.ChineseInvestors.com
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
Receive Text Alerts from CBDWire: Text “Cannabis” to 21000
For more information please visit https://www.cbdwire.com and or https://CBDWire.News
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
